Cardiac Surveillance for Anti-HER2 Chemotherapy P Collier, M Hussain, Z B Popovic, et. al. Cleve…
anti HER2
-
-
JACC: CardioOncology November 01, 2020 | Vol. 2 No. 4 – Table of Contents of…
-
Management of trastuzumab cardiotoxicity (breast and gastric cancer) (Thanks to oncologist Alessandro Inno for sharing this presentation...
-
JACC: CardioOncology June 01, 2020 | Vol. 2 No. 2 – Table of Contents of…
-
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2- positive breast cancer Noam Pondé, Lieveke Ameye, Matteo…
-
JACC: CardioOncology September 01, 2019 | Vol. 1 No. 1 – Table of Contents of…
-
Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human…
-
Risk of Cardiomyopathy in Breast Cancer: How Can We Attenuate the Risk of Heart Failure…
-
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast…